Welcome to OBR Finance where we track the market performance of oncology companies and products, and compare our performance versus other indices.
To find out more about a company click on the company name to see a brief profile.
DJIA 10467.16 -30.72 (-0.29%)
NASDAQ Composite 2251.69 0.00 (+0%)
NASDAQ Biotech 822.41 0.00 (+0%)
Industry Performance Indicators
Cancer Patient Volume
How is this calculated? Source: IntrinsiQ, LLC
Cancer Drug Dollar Volume
How is this calculated? Source: IntrinsiQ, LLC
OBR Index 948.51 0.00 (+0%)
The OBR Index is a market capitalization index. The index is comprised of OBR Finance companies with market cap values over $50M. The sharp increase in the OBR Index value in February is due to a change in the parameters used to calculate the index.
An OBR Finance Bull is a company stock that is trading above its 200 day moving average, and a OBR Finance Bear is a company stock that is trading below their 200 day moving average.
The OBR Bullish Percentage calculates the percentage of Tumor Ticker companies trading above their 200 day moving average.
These values are important because they are an indicator as to whether the stocks in the OBR Index are overbought or oversold. The OBR Bull/OBR Bear tables may provide a way to correlate company news with changes in share price or may provide an indication as to which stocks in the OBR index are being speculated on.
An OBR Bull is a company stock that is trading above its 200 day moving average.
The OBR Bullish Percentage calculates the percentage of OBR Finance companies trading above their 200 day moving average.
These values are important because they are an indicator as to whether the stocks in the OBR Index are overbought or oversold. The OBR Bull/OBR Bear tables may provide a way to correlate company news with changes in share price or may provide an indication as to which stocks in the OBR index are being speculated on.
An OBR Bear is a company stock that is trading below their 200 day moving average.
The OBR Bearish Percentage calculates the percentage of OBR Finance companies trading below their 200 day moving average.
These values are important because they are an indicator as to whether the stocks in the OBR Index are overbought or oversold. The OBR Bull/OBR Bear tables may provide a way to correlate company news with changes in share price or may provide an indication as to which stocks in the OBR index are being speculated on.
The Cancer Patient Volume Index calculates relative cancer patient volume on a monthly basis by summing the total patients (all lines of therapy including metastatic, adjuvant, and maintenance) receiving Avastin, Erbitux, Gemzar, Gleevec, Herceptin, Revlimid, Rituxan, and Sutent. The total projected patient population in the first month of tracking (August '09) was set to a value of 100 and then recalculated each month to provide a relative value. Brought to you by IntrinsiQ LLC. For more information contact Maria Rugani at mrugani@intirnisq.com or editor@oncbiz.com.
The Cancer Drug Dollar Volume Index calculates the relative cancer drug dollar volume on a monthly basis by summing the total dollars spent in breast cancer, colorectal cancer, kidney and renal pelvis cancer, non-Hodgkin's lymphoma, and non-small cell lung cancer (all lines of therapy including metastatic, adjuvant, and maintenance). The total cancer drug dollar volume in the first month of tracking (August '09) was set to a value of 100 and then recalculated each month to provide a relative value. Brought to you by IntrinsiQ LLC. For more information contact Maria Rugani at mrugani@intirnisq.com or editor@oncbiz.com.
OBR Finance
Quotes Are Updated Every 20 Minutes.
Major Players: Market Cap > $50M (sorted descending by Market Cap)
Micro Cap < $50M (sorted descending by Market Cap)